肿瘤微环境
间质细胞
癌症研究
生物
免疫系统
重编程
免疫疗法
细胞代谢
脂肪酸代谢
代谢途径
新陈代谢
脂质代谢
β氧化
脂肪酸
癌症
肿瘤进展
细胞
机制(生物学)
细胞生物学
生物信息学
癌症免疫疗法
炎症
免疫学
mTORC1型
作者
X. Sun,Yuhan Shen,Xingyan Lv,Jiaxin Tian,Xiaoshuo Dai,Jing Lu
标识
DOI:10.1016/j.critrevonc.2026.105259
摘要
Gastrointestinal (GI) tumors, characterized by high incidence and mortality rates, represent a major global health challenge. Metabolic reprogramming has been recognized as one of their defining hallmarks. Beyond aberrant glucose metabolism, accumulating evidence has revealed how dysregulated fatty acid (FA) metabolism plays a multifaceted role in regulating the tumor microenvironment (TME). By modulating tumor, immune, and stromal cells, FA metabolism profoundly influences tumorigenesis, progression, and cell death. Despite advances in current treatments, the inherent immunosuppressive nature of TME and the therapeutic resistance of tumor cells still remain major obstacles. Notably, targeting key nodes of FA metabolism has emerged as a promising strategy to overcome these challenges. Thus, in this review, we systematically delineate how FA metabolic reprogramming shapes the GI tumor microenvironment by regulating tumor, immune, and stromal cells in multiple ways. Furthermore, we critically explore the translational potential of FA metabolism in biomarker development, targeted therapy, and combination therapeutic strategies. By synthesizing these insights, this review aims to provide forward-looking perspectives on future therapeutic strategies against GI tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI